Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
4.290
-0.020 (-0.46%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,424,480
Open
4.310
Bid (Size)
4.290 (10)
Ask (Size)
4.380 (10)
Prev. Close
4.310
Today's Range
4.185 - 4.395
52wk Range
4.090 - 9.260
Shares Outstanding
412,429,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
November 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Why GoodRx Holdings Stock Was Sinking This Week
November 08, 2024
The company is growing key fundamentals. However, the improvements weren't enough to impress the market.
Via
The Motley Fool
Performance
YTD
-23.67%
-23.67%
1 Month
-35.00%
-35.00%
3 Month
-43.25%
-43.25%
6 Month
-40.75%
-40.75%
1 Year
-26.54%
-26.54%
More News
Read More
GoodRx (GDRX) Q3 2024 Earnings Call Transcript
November 07, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
GoodRx Reports Third Quarter 2024 Results
November 07, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
August 16, 2024
Via
Benzinga
GoodRx to Participate in Upcoming Investor Conferences
November 04, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Unveils New E-commerce Platform, Launches with Opill®
October 31, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
October 29, 2024
From
GoodRx
Via
Business Wire
Ronald E. Bruehlman Joins GoodRx Board of Directors
October 28, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
October 23, 2024
From
GoodRx
Via
Business Wire
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
October 16, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
October 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
September 26, 2024
From
GoodRx
Via
Business Wire
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GoodRx to Participate in Upcoming Investor Conferences
August 21, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx (GDRX) Q2 2024 Earnings Call Transcript
August 08, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges
August 08, 2024
Via
Benzinga
GoodRx Reports Second Quarter 2024 Results
August 08, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday
July 15, 2024
Via
Benzinga
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call
July 11, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Ian T. Clark Joins GoodRx Board of Directors
July 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
3 Lawsuit-Laden Stocks to Dump Before Problems Multiply
July 10, 2024
Via
InvestorPlace
Market Correction Alert: Sell These 3 Tech Stocks While You Can
June 28, 2024
Via
InvestorPlace
GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
June 26, 2024
From
GoodRx
Via
Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
June 21, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.